Academic Journal

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells.

التفاصيل البيبلوغرافية
العنوان: The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells.
المؤلفون: Storti, Paola, Toscani, Denise, Airoldi, Irma, Marchica, Valentina, Maiga, Sophie, Bolzoni, Marina, Fiorini, Elena, Campanini, Nicoletta, Martella, Eugenia, Mancini, Cristina, Guasco, Daniela, Ferri, Valentina, Donofrio, Gaetano, Aversa, Franco, Amiot, Martine, Giuliani, Nicola
المساهمون: Department of Clinical and Experimental Medicine, Università degli studi di Parma = University of Parma (UNIPR), Laboratorio di Oncologia, Istituto Giannina Gaslini, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Université d'Angers (UA)-Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Azienda Ospedaliero-Universitaria of Parma, Department of Biotechnology and Life Sciences, Universitá degli Studi dell’Insubria = University of Insubria Varese (Uninsubria), Department of Medical-Veterinary Science, This work was supported in part by a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC) IG2014 n°15531 (NG).
المصدر: ISSN: 0390-6078.
بيانات النشر: HAL CCSD
Ferrata Storti Foundation
سنة النشر: 2016
مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer
الوصف: International audience ; The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells We investigated the effect of stable suppression of hypoxia inducible factor (HIF)-1α in myeloma cells on sensitivity to lenalidomide (LEN) in vivo. We found that the in vivo anti-tumoral effect of LEN is enhanced by HIF-1α suppression in myeloma cells. It has been reported that HIF-1α is over-expressed by myeloma cells 1-4 and that HIF-1α suppression significantly blocks myeloma-induced angiogenesis, and reduces both tumoral burden and bone destruction in vivo in multiple myeloma (MM) mouse models. 3 The potential effects of HIF-1α modulation on drug sensitivity in MM cells are not known and are currently under investigation. The immunomodulatory drugs (IMiDs®), including LEN, are a class of drugs derived from thalidomide 4 able to exert anti-myeloma effects by the selective Cereblon-dependent destruction of IKZF proteins, 5,6 either through a direct action on MM cell proliferation and survival, 7 or through indirect immunomodulatory and anti-angiogenic effects. 7 Previous data indicated that HIF-1α inhibition did not increase the anti-proliferative in vitro effect of bortezomib on MM cells; 2,3 this drug induces a strong downregula-tion of HIF-1α in MM cells. 2 We recently reported that HIF-1α knockdown in the human myeloma cell line (HMCL) JJN3 potentiated the in vitro effect of LEN treatment (48-72 h) on cell proliferation through a significant upregulation of p27 without changing cell viability. 3 It has been consistently reported that LEN only slightly down-regulated HIF-1α expression in MM cells. 2 Such evidence has provided the rationale to investigate the effect of stable suppression of HIF-1α in myeloma cells on LEN sensitivity in vivo. Therefore, in the present study, we first inhibited HIF-1α in three HMCLs (JJN3, OPM2 and H929) using an anti-HIF1α lentiviral shRNA pool, as previously described. 3 H929 showed a very high mortality rate after anti-HIF1α ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/26659917; inserm-01285193; https://inserm.hal.science/inserm-01285193; https://inserm.hal.science/inserm-01285193/document; https://inserm.hal.science/inserm-01285193/file/giuliani_amiot.pdf; PUBMED: 26659917
DOI: 10.3324/haematol.2015
الاتاحة: https://inserm.hal.science/inserm-01285193
https://inserm.hal.science/inserm-01285193/document
https://inserm.hal.science/inserm-01285193/file/giuliani_amiot.pdf
https://doi.org/10.3324/haematol.2015
Rights: info:eu-repo/semantics/OpenAccess
رقم الانضمام: edsbas.7BF3DAEA
قاعدة البيانات: BASE